Authors: Beer, TM Pierce, WC Lowe, BA Henner, WD

Citation: Tm. Beer et al., Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer, ANN ONCOL, 12(9), 2001, pp. 1273-1279

Authors: Henner, WD Evans, AJ Hough, KM Harris, EL Lowe, BA Beer, TM

Citation: Wd. Henner et al., Association of codon 72 polymorphism of p53 with lower prostate cancer risk, PROSTATE, 49(4), 2001, pp. 263-266

Authors: Beer, TM Hough, KM Garzotto, M Lowe, BA Henner, WD

Citation: Tm. Beer et al., Weekly high-dose calcitriol and docetaxel in advanced prostate cancer, SEMIN ONCOL, 28(4), 2001, pp. 49-55

Authors: Garzotto, M Beer, TM

Citation: M. Garzotto et Tm. Beer, Syndrome of inappropriate antidiuretic hormone secretion: A rare complication of prostate cancer, J UROL, 166(4), 2001, pp. 1386-1386

Authors: Beer, TM Munar, M Henner, WD

Citation: Tm. Beer et al., A phase I trial of pulse calcitriol in patients with refractory malignancies - Pulse dosing permits substantial dose escalation, CANCER, 91(12), 2001, pp. 2431-2439

Authors: McWilliams, JE Evans, AJ Beer, TM Andersen, PE Cohen, JI Everts, EC Henner, WD

Citation: Je. Mcwilliams et al., Genetic polymorphisms in head and neck cancer risk, HEAD NECK, 22(6), 2000, pp. 609-617